ANCO's ASCO/ONS Highlights 2008

ANCO's ASCO/ONS Highlights 2008
Saturday, September 6th, 2008, 8:00AM-1:00PM
The Claremont Resort • Ashby & Domingo Avenues
Oakland, California • (510) 843-3000

ASSOCIATION OF NORTHERN CALIFORNIA ONCOLOGISTS
&
INDIANA UNIVERSITY SCHOOL OF MEDICINE

Program Overview
ASCO/ONS Highlights 2008 will summarize the major research and treatment advancements presented at this year’s ONS Congress and ASCO Annual Meeting. The program will focus on breast, gastrointestinal, genitourinary, gynecologic, and lung cancers as well as hematological malignancies. The faculty will place these developments in context as to their immediate clinical utility. A plenary talk on pharmacogenomics will also be presented.

Download the meeting announcement and registration form at www.anco-online.org/ascohl2008.pdf.

Educational Objectives
At the conclusion of this educational activity, participants should be able to:

• Review, summarize, and interpret new advances and implement changes in the treatment of breast, genitourinary, gynecologic, gastrointestinal, and lung cancers and hematological malignancies presented at the 2008 ASCO Annual Meeting.

• Review, summarize, and interpret new advances and implement changes in oncology nursing presented at the 2008 ONS Congress.

Target Audience
ASCO/ONS Highlights 2008 has been designed to meet the educational needs of oncologists, oncology nurses, oncology pharmacists, and other health-care professionals involved in the care of people with cancer.

Accreditation
This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of Indiana University School of Medicine and the Association of Northern California Oncologists (ANCO).

Designation of Credit
The Indiana University School of Medicine is accredited by the ACCME to provide continuing medical education for physicians. The Indiana University School of Medicine designates this educational activity for a maximum of 4.25 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity. The California State Board of Registered Nurses accepts courses approved for AMA PRA Category 1 Creditä as meeting the continuing education requirements for renewal.

Disclosure Statement
In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Commercial Support, educational programs sponsored by the Indiana University School of Medicine (IUSM) must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, and Planning Committee members participating in IUSM-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.

Program Planning Committee
The Physician Course Director for ASCO/ONS Highlights 2008 is David R. Gandara, MD, Univ. of California, Davis. Dr. Gandara was assisted by the ANCO Board of Directors (Richard A. Bohannon, MD, Norman Cohen, MD, Jeffrey Cronk, MD, Bradley Ekstrand, MD, Ellie Guardino, MD, PhD, John A. Keech, Jr., DO, L. Wayne Keiser, MD, Primo Lara, Jr., MD, Daniel P. Mirda, MD, Bimal J. Patel, MD, Robert L. Robles, MD, and Antoine Sayegh, MD), Institutional Member contacts (George A. Fisher, MD, Hope Rugo, MD, and Margaret Tempero, MD), and Group Member contact (Joseph Mason, MD) in the selection of the faculty for ASCO/ONS Highlights 2008.

Content Consultant
The Indiana University School of Medicine content consultant is Lawrence Einhorn, MD.

Supporters & Exhibitors
This educational activity is supported in part by AMGEN, AstraZeneca, Bayer HealthCare Pharmaceuticals/Onyx Pharmaceuticals, biogenIDEC, Celgene, Eisai, Enzon Pharmaceuticals, Genentech BioOncology, Genomic Health, Genzyme Oncology, GlaxoSmithKline, Imclone Systems, Millennium, Novartis Oncology, Ortho Biotech, OSI Pharmaceuticals, Pfizer Oncology, Roche Oncology, Sanofi Aventis Oncology, and possibly others (as of the date of this mailing). The final list of supporters and exhibitors will be available at the meeting.

Agenda & Faculty
7:00AM
REGISTRATION, EXHIBITS, AND BUFFET BREAKFAST (available through 9:00AM)
8:00AM
OPENING REMARKS & INTRODUCTION
David R. Gandara, MD, Program Moderator
8:15AM
PHARMACOGENOMICS
Heinz-Josef Lenz, MD, Univ of Southern Calif
9:00AM
HEMATOLOGICAL MALIGNANCIES
Jeffrey Wolf, MD, Univ of Calif, San Francisco
9:30AM
LUNG CANCER
David R. Gandara, MD, Univ of Calif, Davis
10:00AM
GASTROINTESTINAL CANCER
Andrew H. Ko, MD, Univ of Calif, San Francisco
10:30AM
BREAK
11:00AM
ONCOLOGY NURSING
Patricia Palmer, RN, MS, AOCNS, Univ of Calif, Davis
11:30AM
GENITOURINARY CANCER
Sandy Srinivas, MD, Stanford Univ
12:00PM
GYNECOLOGIC CANCER
Sidney A. Scudder, MD, Univ of Calif, Davis
12:30PM
BREAST CANCER
Louis Fehrenbacher, MD
The Permanente Medical Group
1:00PM
ADJOURN